Malignancy rates in thyroid nodules classified as benign according to the nodule size threshold of 4 cm

Yıl 2024, , 26 - 34, 30.04.2024

Yunushan Furkan Aydoğdu , Emre Gülçek , Çağrı Büyükkasap , Kürşat Dikmen

https://doi.org/10.33716/bmedj.1424770

Öz

SUMMARY
Aim: The false negative rate of fine needle aspiration biopsy (FNAB) in large thyroid nodules ranges from 7.7% to 53%. The treatment of nodules that are 4 cm or larger is controversial because of the potential for false-negative FNAB results. In order to make treatment recommendations for nodules ≥4 cm in size, we compared the results of preoperative FNAB with thyroid surgery specimens.
Materials and Methods: We evaluated patients who underwent thyroid surgery and had preoperative FNAB between 2017 and 2022. Patients were divided into two groups based on nodule size (<4 cm and ≥4 cm). FNAB and specimen pathology results of both groups were compared.
Results: 982 patients who underwent surgery for nodular disease were evaluated. Patients in the Bethesda 2 group (n=231) were divided into two categories based on nodule size: ≥4 cm (n=56) and <4 cm (n=175). Malignancy rates were higher in the group with tumors smaller than 4 cm. FNAB and specimen results were compared. A statistically significant difference was found between the groups (p = 0.039).
Conclusion: The benign fine-needle aspiration biopsy results were consistent with the specimen results in patients with nodules that were 4 cm or larger. Thyroid surgery should not be considered as the initial treatment for nodules ≥4 cm with benign cytology.

Anahtar Kelimeler

Thyroid cancer, Nodular thyroid disease, Fine needle aspiration biopsy, Thyroidectomy, False negative rate

Nodül boyutu 4 cm üzerinde benign olarak sınıflandırılan tiroid nodüllerinde malignite oranları

Öz

ÖZET
Amaç: Büyük tiroid nodüllerinde ince iğne aspirasyon biyopsisinin (İİAB) yanlış negatiflik oranı %7,7 ile %53 arasında değişmektedir. Yanlış negatif İİAB sonuçları potansiyeli nedeniyle 4 cm veya daha büyük nodüllerin tedavisi tartışmalıdır. Büyüklüğü 4 cm ve üzerindeki nodüllere tedavi önerilerinde bulunmak amacıyla preoperatif İİAB sonuçlarını tiroid cerrahisi spesmenleri ile karşılaştırdık.
Gereç ve Yöntem: 2017-2022 yılları arasında tiroid ameliyatı geçiren ve ameliyat öncesi İİAB yapılan hastaları değerlendirdik. Hastalar nodül boyutlarına göre (<4 cm ve ≥4 cm) iki gruba ayrıldı. Her iki grubun İİAB ve spesmen patoloji sonuçları karşılaştırıldı.
Bulgular: Nodüler hastalık nedeniyle ameliyat edilen 982 hasta değerlendirildi. Bethesda 2 grubundaki hastalar (n=231) nodül boyutlarına göre ≥4 cm (n=56) ve <4 cm (n=175) olmak üzere iki kategoriye ayrıldı. Tümörü 4 cm'den küçük olan grupta malignite oranları daha yüksekti. İİAB ve spesmen sonuçları karşılaştırıldı. Gruplar arasında istatistiksel olarak anlamlı fark bulundu (p=0,039).
Sonuç: Nodülü 4 cm ve üzerinde olan hastalarda benign ince iğne aspirasyon biyopsisi sonuçları spesmen sonuçlarıyla uyumluydu. Benign sitolojiye sahip ≥4 cm nodüllerde tiroid cerrahisi ilk tedavi seçeneği olarak düşünülmemelidir.

Anahtar Kelimeler

Tiroid kanseri, Nodüler tiroid hastalığı, İnce iğne aspirasyon biyopsisi, Tiroidektomi, Yanlış negatiflik oranı

Kaynakça

• Altiner, S., Kozan, R., Emral, A. C., Taneri, F., & Karamercan, A. (2022). Effects of patient and tumor characteristics on central lymph node metastasis in papillary thyroid cancer: a guide for selective node dissection. Archives of Iranian Medicine, 25(11), 730-736.
• Amrikachi, M., Ramzy, I., Rubenfeld, S., & Wheeler, T. M. (2001). Accuracy of fine-needle aspiration of thyroid: a review of 6226 cases and correlation with surgical or clinical outcome. Archives of pathology & laboratory medicine, 125(4), 484-488.
• Baser, O. O., Koseoglu, D., Cetin, Z., Catak, M., & Kizilkaya, H. (2022). Benign cytology does not rule out malignancy in thyroid nodules larger than 4 cm. Diagnostic cytopathology, 50(11), 508-512.
• Carrillo, J. F., Frias-Mendivil, M., Ochoa-Carrillo, F. J., & Ibarra, M. (2000). Accuracy of fine-needle aspiration biopsy of the thyroid combined with an evaluation of clinical and radiologic factors. Otolaryngology—Head and Neck Surgery, 122(6), 917-921.
• Cibas, E. S., Alexander, E. K., Benson, C. B., De Agustín, P. P., Doherty, G. M., Faquin, W. C., Middleton, W. D., Miller, T., Raab, S. S., & White, M. L. (2008). Indications for thyroid FNA and pre‐FNA requirements: a synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science Conference. Diagnostic cytopathology, 36(6), 390-399.
• Cibas, E. S., & Ali, S. Z. (2017). The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid, 27(11), 1341-1346.
• Giles, W. H., Maclellan, R. A., Gawande, A. A., Ruan, D. T., Alexander, E. K., Moore, F. D., & Cho, N. L. (2015). False negative cytology in large thyroid nodules. Annals of surgical oncology, 22, 152-157.
• HaugenBryan, R., AlexanderErik, K., BibleKeith, C., DohertyGerard, M., MandelSusan, J., NikiforovYuri, E., RandolphGregory, W., SawkaAnna, M., SchuffKathryn, G., & ShermanSteven, I. (2016). 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid.
• Hou, Y., Gao, Y., Guo, S., Zhang, Z., Chen, R., & Zhang, X. (2023). Applications of spatially resolved omics in the field of endocrine tumors. Frontiers in Endocrinology, 13, 993081.
• Kim, H. K., Kim, S. Y., Lee, Y. S., Soh, E. Y., Chang, H.-S., & Park, C. S. (2022). Suspicious thyroid nodules 4 cm require a diagnostic lobectomy regardless of their benign fine needle aspiration results. Asian Journal of Surgery, 45(5), 1113-1116.
• Lee, L., Mitmaker, E. J., Chabot, J. A., Lee, J. A., & Kuo, J. H. (2016). Cost-effectiveness of diagnostic lobectomy versus observation for thyroid nodules> 4 cm. Thyroid, 26(2), 271-279.
• McCoy, K. L., Jabbour, N., Ogilvie, J. B., Ohori, N. P., Carty, S. E., & Yim, J. H. (2007). The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery, 142(6), 837-844. e833.
• Mehanna, R., Murphy, M., McCarthy, J., O'Leary, G., Tuthill, A., Murphy, M. S., & Sheahan, P. (2013). False negatives in thyroid cytology: impact of large nodule size and follicular variant of papillary carcinoma. The Laryngoscope, 123(5), 1305-1309.
• Meko, J. B., & Norton, J. A. (1995). Large cystic/solid thyroid nodules: a potential false-negative fine-needle aspiration. Surgery, 118(6), 996-1004.
• Pinchot, S. N., Al-Wagih, H., Schaefer, S., Sippel, R., & Chen, H. (2009). Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or larger. Archives of surgery, 144(7), 649-655.
• Popoveniuc, G., & Jonklaas, J. (2012). Thyroid nodules. Medical Clinics of North America, 96(2), 329-349.
• Russ, G., Bonnema, S. J., Erdogan, M. F., Durante, C., Ngu, R., & Leenhardt, L. (2017). European Thyroid Association guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS. European thyroid journal, 6(5), 225-237.
• Shi, H., Bobanga, I., & McHenry, C. R. (2017). Are large thyroid nodules classified as benign on fine needle aspiration more likely to harbor cancer? The American Journal of Surgery, 213(3), 464-466.
• Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer statistics, 2018. CA: a cancer journal for clinicians, 68(1), 7-30.
• Wharry, L. I., McCoy, K. L., Stang, M. T., Armstrong, M. J., LeBeau, S. O., Tublin, M. E., Sholosh, B., Silbermann, A., Ohori, N. P., & Nikiforov, Y. E. (2014). Thyroid nodules (≥ 4 cm): can ultrasound and cytology reliably exclude cancer? World journal of surgery, 38, 614-621.
• Wong, R., Farrell, S. G., & Grossmann, M. (2018). Thyroid nodules: diagnosis and management. Medical Journal of Australia, 209(2), 92-98.